Skip to main content
3D Medicines Inc. logo

3D Medicines Inc. — Investor Relations & Filings

Ticker · 1244 ISIN · KYG8872R1011 HKEX Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2025-06-30 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 1244

About 3D Medicines Inc.

https://www.3d-medicines.com

3D Medicines Inc. is an oncology-focused, commercial-stage biopharmaceutical company specializing in the development and commercialization of next-generation immuno-oncology therapies. The company leverages global research and development capabilities and internal discovery platforms to advance a pipeline of innovative drug candidates. Its core mission is to address unmet medical needs in cancer treatment, aiming to transform cancer into a chronic disease and provide substantial value to patients and healthcare providers globally.

Recent filings

Filing Released Lang Actions
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 30, 2025&#x3b; (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR&#x3b; AND (3) CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an announcement of the poll results from the Annual General Meeting held on June 30, 2025, detailing the votes for each resolution, followed by the formal appointment of a non-executive director and change in audit committee composition. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-06-30 English
Form of proxy for the Annual General Meeting to be held on Monday, June 30, 2025
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Form of Proxy for the Annual General Meeting, which is a solicitation of shareholder votes and provides information on resolutions and voting procedures. This corresponds to materials sent to shareholders to request votes for a meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-06-05 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a formal Notice of Annual General Meeting of 3D Medicines Inc., detailing the time, venue, agenda items, resolutions to be voted on, and proxy voting instructions. It is not the full annual report or financial statements, nor an earnings release; rather, it is information provided to shareholders to solicit votes for the upcoming AGM. This corresponds to a Proxy Solicitation & Information Statement (PSI).
2025-06-05 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF RETIRING DIRECTORS&#x3b; PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR&#x3b; RE-APPOINTMENT OF AUDITOR&#x3b; AND NOTICE OF
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a shareholder circular issued by 3D Medicines Inc. to provide detailed background on resolutions to be voted on at the upcoming Annual General Meeting (AGM), including general mandates to issue and repurchase shares, re-election of directors, appointment of a non-executive director, re-appointment of auditor, and the formal Notice of AGM together with proxy instructions. It is a solicitation of shareholder votes and an information statement for the AGM, fitting the definition of a Proxy Solicitation & Information Statement rather than the report itself or a brief announcement.
2025-06-05 English
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE
Board/Management Information Classification · 91% confidence The document is a Hong Kong Exchange announcement detailing the retirement of a non-executive director, the proposed appointment of a new non-executive director, and a change in the composition of the audit committee. This clearly pertains to board and senior management changes rather than financial results, statutory filings, or other corporate actions. Therefore it falls under Board/Management Information (MANG).
2025-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Share Issue/Capital Change Classification · 85% confidence The document is a Form FF301 Monthly Return filed with Hong Kong Exchanges and Clearing Limited detailing the movements in authorized share capital, issued shares, share options, and other capital structure items for 3D Medicines Inc. It is a periodic regulatory submission under the Listing Rules focused exclusively on changes in the company’s share capital. This fits the category for announcements regarding share capital changes.
2025-06-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.